Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR-/- mice

Dawn Thompson* (Corresponding Author), Shehroz Mahmood, Nicola Morrice, Sarah Kamli-Salino, Ruta Dekeryte, Philip Hoffmann, Mary K Doherty, Philip D. Whitfield, Mirela Delibegović, Nimesh Mody* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR-/- mice'. Together they form a unique fingerprint.

Medicine & Life Sciences